Keywords: celgene, halts, revlimid, trial, corp, usa, said

Celgene halts Revlimid trial

Article | 10 May 2004

Print This

Celgene Corp of the USA has said it plans to stop a pivotal Phase III monotherapy trial of Revlimid (CC-5013; ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in